Xenetic Biosciences (XBIO) Enterprise Value (2023 - 2025)
Xenetic Biosciences' Enterprise Value history spans 6 years, with the latest figure at -$7.9 million for Q4 2025.
- For Q4 2025, Enterprise Value fell 27.87% year-over-year to -$7.9 million; the TTM value through Dec 2025 reached -$7.9 million, down 27.87%, while the annual FY2025 figure was -$7.9 million, 27.87% down from the prior year.
- Enterprise Value reached -$7.9 million in Q4 2025 per XBIO's latest filing, down from -$4.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.1 million in Q3 2025 to a low of -$12.0 million in Q1 2023.
- Average Enterprise Value over 3 years is -$7.6 million, with a median of -$7.6 million recorded in 2024.
- The largest YoY upside for Enterprise Value was 39.74% in 2025 against a maximum downside of 27.87% in 2025.
- A 3-year view of Enterprise Value shows it stood at -$9.0 million in 2023, then skyrocketed by 31.36% to -$6.2 million in 2024, then decreased by 27.87% to -$7.9 million in 2025.
- Per Business Quant, the three most recent readings for XBIO's Enterprise Value are -$7.9 million (Q4 2025), -$4.1 million (Q3 2025), and -$4.8 million (Q2 2025).